Affiliation:
1. Aging and Cardiovascular Discovery Center, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA
2. Department of Biomedical Education, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA
Abstract
A role for substance P has been proposed in musculoskeletal fibrosis, with effects mediated through transforming growth factor beta (TGFβ). We examined the in vitro effects of substance P on proliferation, collagen secretion, and collagen deposition in rat primary dermal fibroblasts cultured in medium containing 10% fetal bovine serum, with or without TGFβ. In six-day cultures, substance P increased cell proliferation at concentrations from 0.0002 to 100 nM. TGFβ increased proliferation at concentrations from 0.0002 to 2 pg/mL, although higher concentrations inhibited proliferation. Substance P treatment alone at concentrations of 100, 0.2, and 0.00002 nM did not increase collagen deposition per cell, yet when combined with TGFβ (5 ng/mL), increased collagen deposition compared to TGFβ treatment alone. Substance P treatment (100 nM) also increased smooth muscle actin (SMA) expression at 72 h of culture at a level similar to 5 ng/mL of TGFβ; only TGFβ increased SMA at 48 h of culture. Thus, substance P may play a role in potentiating matrix deposition in vivo when combined with TGFβ, although this potentiation may be dependent on the concentration of each factor. Treatments targeting substance P may be a viable strategy for treating fibrosis where both substance P and TGFβ play roles.
Funder
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Reference55 articles.
1. Biogenic Amines and Active Polypeptides of the Amphibian Skin;Erspamer;Annu. Rev. Pharmacol.,1971
2. Structure, expression, and some regulatory mechanisms of the rat preprotachykinin gene encoding substance P, neurokinin A, neuropeptide K, and neuropeptide gamma;Carter;J. Neurosci.,1990
3. Tachykinins and their receptors: Contributions to physiological control and the mechanisms of disease;Steinhoff;Physiol. Rev.,2014
4. Melendez, G.C., Kavanagh, K., Gharraee, N., Lacy, J.L., Goslen, K.H., Block, M., Whitfield, J., Widiapradja, A., and Levick, S.P. (2023). Replacement substance P reduces cardiac fibrosis in monkeys with type 2 diabetes. Biomed. Pharmacother., 160.
5. Substance P modulates colitis-associated fibrosis;Koon;Am. J. Pathol.,2010